See the signal in a noisy pharma market.
Demand Lens finds and engages the decision-makers inside pharma, biotech, CRO/CDMO and medtech accounts - and turns that reach into qualified, sales-ready pipeline.
- 100% opted-in, GDPR-aligned data
- Director-led sector expertise
- Pilot-first engagement - proof before commitment
Pharma & biopharma accounts mapped
Emerging & mid-size biotechs profiled
MedTech organisations in active coverage
Global CROs tracked end-to-end
Intelligence, engagement, activation.
Most agencies sell one of these. Demand Lens runs all three as a single programme, so the account you identify is the account you engage and the lead you convert.
Intelligence
Know which life-sciences accounts are moving, and why, before the rest of the market sees it.
Engagement
Reach the clinical, regulatory, commercial and executive people inside those accounts with content they take seriously.
Activation
Convert that reach into qualified leads and booked meetings, delivered to agreed criteria and SLAs.
From account universe to booked meeting.
Target account & contact lists
Bespoke, verified lists across pharma, biotech, CRO/CDMO and medtech - segmented by therapeutic focus, company stage and region.
Persona-level targeting
Clinical operations, medical affairs, regulatory, pharmacovigilance & QA, commercial and C-suite - mapped per account, not guessed.
Demand generation campaigns
Content syndication, ABM display and CTV, social, audio and email activation, run as one coordinated programme.
Event & roundtable audience acquisition
Named, seniority-verified recruitment for executive roundtables, webinars and congress activity.
Nurture & conversion support
Sector-dedicated SDRs and follow-up sequencing that move engaged leads to booked meetings.
Four audiences we know properly.
Coverage is built and maintained per sector, with personas mapped to the way each one actually buys.
Pharma & Biopharma
Large and mid-size pharmaceutical and biopharmaceutical companies, mapped by therapeutic area, pipeline focus and region across the US, Europe and APAC.
Sector detailEmerging & mid-size Biotech
Emerging and mid-size biotechs segmented by modality and therapeutic focus - small molecule, biologics, cell and gene therapy - and by company stage from pre-clinical through commercial.
Sector detailCRO & CDMO
Global and regional contract research, development and manufacturing organisations, tracked across service lines, therapeutic capability and geography.
Sector detailMedTech
Device, diagnostics and medical technology organisations, segmented by product category, regulatory class exposure and region.
Sector detailSpecialists, not a generalist agency with a pharma page.
Vertical specialists, not generalists
SDRs, writers and campaign managers work exclusively on pharma, biotech, CRO/CDMO and medtech accounts. They know the buying committees and the language of clinical development.
Verified, validated life-sciences data
Every record is verified before it reaches a campaign, and the database runs on a regular cleansing cycle. Opted-in and GDPR-aligned throughout.
Full-funnel, not single-channel
Audience intelligence, then engagement across content, email, ABM, display, social, audio and CTV, then activation into qualified leads delivered to defined SLAs.
Senior sector leadership
The life-sciences vertical is led at director level, with hands-on involvement in every account rather than a handover after the pitch.
How we approach a typical engagement.
Method only, no client details. This is how the work runs regardless of sector or channel mix.
We start from your account universe
Not a shelf list. We take the accounts you want to win, confirm how much of that universe is reachable, and say so plainly if the answer is not enough.
We agree what a lead means before running anything
Qualification tier, profiling questions, suppression, concentration limits and delivery template are all written down before the first asset goes live.
We report per lead, not per campaign
Every delivered lead comes with who they are and what they engaged with, so quality can be checked while the pilot is still running.
Pilot first. Proof before commitment.
Every engagement starts as a scoped pilot with defined targeting, lead criteria and SLAs. You see the quality before you commit to a wider campaign.
Scoped pilot
We agree the target accounts, personas, channels, lead criteria and volume in writing before anything runs. Procurement-friendly, with clear SLAs.
Proof of quality
The pilot runs and every lead is reported individually - who they are, what they engaged with, and how they met the agreed criteria.
Wider campaign
Only once the pilot has proved lead quality do we scope a larger, multi-channel programme. Proof before commitment.
Start with a scoped pilot.
Tell us the accounts you want to reach and the lead criteria you work to. We'll come back with a scoped pilot within one working day.
Start a pilot